Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Support us today
Not now
Wednesday 1 February 2023 Dublin: 10°C

# coronavirus newsletter

Last month
January 2023
# XBB.1.5
We need to talk about the 'Kraken' variant: What is it, and do we know what impact it could have?
XBB.1.5 is uniquely good at breaking the ‘door’ to the human body, but it’s not clear how much of a surge in cases it could cause.
Last year
# Boosters
HSE vaccine lead: 'Plans in development for autumn booster as well as winter emergencies'
The HSE’s Damien McCallion gave The Journal’s Coronavirus Newsletter an insight into the next stages of the vaccine rollout.
# coronavirus newsletter
'Stronger mask advice wouldn't end this Covid wave, but would help slow it down'
Christine Loscher said strong new public health advice on masks would help ease pressure on hospitals.
# exit wave
Virologist: 'Free mass antigen testing could help break this wave of Covid'
Both case numbers and the number of people requiring hospital treatment with the virus are rising, but no action has yet been taken by government.
# coronavirus newsletter
The new Covid antibody and antiviral treatments currently (or imminently) available in Ireland
An antibody treatment is currently being used in Irish hospitals, and the first deliveries of a new antiviral pill are expected later this month.
# coronavirus newsletter
Do boosted close contacts need to restrict their movements?
Well, about that…
All time
# coronavirus newsletter
Antigen tests: How do they work, when do I use them, and how accurate are they?
A debate is raging yet again on their usage.
# coronavirus newsletter
Not just a cough and a fever: What we know about Covid-19's symptoms now
We all need to be on the lookout for a myriad of different symptoms.
# Coronavirus
Looking for clear, up-to-date information on coronavirus and Ireland's response to it? Sign up to our newsletter
Our hugely popular newsletter brings you the latest developments.